Charlotte E. Joslin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Charlotte E. Joslin has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
Faith G. Davis
3-317 Edmonton Clinic Health Academy, University of Alberta School of Public Health, 11405 87 Avenue, Edmonton, AB, T6G 1C9, Canada
5 shared publications- Elmer Yuchen Tu
Department of Ophthalmology and Visual Sciences, University of Illinois Chicago, Chicago, IL
4 shared publications - Caryn E. Peterson
University of Illinois Chicago
3 shared publications Katherine C. Brewer
Department of Epidemiology and Biostatistics, University of Illinois at Chicago, 1603 W. Taylor Ave., Chicago, IL, 60612, USA
3 shared publicationsThasarat S. Vajaranant
Department of Ophthalmology and Visual Sciences, College of Medicine, University of Illinois Chicago
3 shared publicationsJoel Sugar
University of Illinois at Chicago, Department of Ophthalmology and Visual Sciences, School of Public Health, Chicago, IL
2 shared publications
Latest Publications
- Open Access
- 1 June 2026
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 9 (6) , e2617975
Visual Impairment and Cardiovascular Risk Factors in Hispanic and Latino Adults
Importance: Visual impairment (VI) affects approximately 7 million individuals in the US and is associated with adverse outcomes; cardiovascular disease (CVD) risk factors and nonmedical drivers of health (NMDOH) may contribute. Prior research in Mexican American individuals suggested high VI prevalence, but data across more diverse US Hispanic/Latino populations remain limited. Objective: To estimate VI prevalence and assess its associations with CVD risk factors in Hispanic/Latino adults in the US. Design, Setting, and Participants: This cross-sectional study analyzed data from SOL Ojos, an ancillary study of the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Participants were Hispanic/Latino adults aged 40 years or older from community-based cohorts in Chicago, Illinois, and Miami, Florida, who completed HCHS/SOL visit 3 (2020-2024) and were recruited into SOL Ojos from July 1, 2021, to July 1, 2023. Exposures: Individual and cumulative major CVD risk factors: diabetes, hypercholesterolemia, hypertension, obesity, and smoking. Main Outcome and Measures: Age-standardized VI (visual acuity less than or equal to 20/40 in the better-seeing eye), assessed by habitual visual acuity, best-corrected visual acuity, and uncorrected refractive error (correctable to more than 20/40). Odds ratios (ORs) for VI by CVD risk factors were estimated using logistic regression, sequentially adjusting for traditional, biologic, and NMDOH-related confounders. Age-standardized weighted estimates reflected the target population. Results: Among 3288 participants (mean age, 58.7 [95% CI, 57.9-59.5] years; 61.9% [95% CI, 60.2%-63.5%] female), VI prevalence by habitual visual acuity was 7.1% (95% CI, 5.3%-8.8%) in men vs 7.0% (95% CI, 5.2%-8.8%) in women and by best-corrected visual acuity was 1.8% (95% CI, 1.0%-2.6%) in men vs 2.6% (95% CI, 1.6%-3.7%) in women; VI by uncorrected refractive error was 5.2% (95% CI, 3.7%-6.8%) in men vs 4.4% (95% CI, 3.0%-5.8%) in women. VI prevalence varied across Hispanic/Latino backgrounds in men (habitual visual acuity VI range, 4.1% [95% CI, 1.8%-6.4%] to 16.9% [95% CI, 11.6%-22.2%]; uncorrected refractive error range, 2.3% [95% CI, 0.6%-4.0%] to 13.5% [95% CI, 8.1%-18.9%]) and was highest among Mexican men. In fully adjusted models, diabetes was associated with VI assessed by best-corrected visual acuity (OR, 4.65; 95% CI, 2.42-8.91), as were cumulative CVD risk factors vs 1 or none (3 factors: OR, 3.47 [95% CI, 1.45-8.33]; ≥4 factors: OR, 9.80 [95% CI, 4.34-22.13]). ORs were smaller when VI was assessed by habitual visual acuity (eg, diabetes OR, 2.03 [95% CI, 1.37-3.01]). Conclusions and Relevance: In this cross-sectional study of US Hispanic/Latino adults, VI and CVD risk factor prevalence varied by ethnic background, and diabetes and cumulative CVD risk factors were associated with VI. The findings provide updated prevalence estimates and support the need for longitudinal studies of causal relationships between VI and CVD risk factors.
- 1 June 2026
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 9 (6) , e2617975
Open AccessVisual Impairment and Cardiovascular Risk Factors in Hispanic and Latino Adults
Importance: Visual impairment (VI) affects approximately 7 million individuals in the US and is associated with adverse outcomes; cardiovascular disease (CVD) risk factors and nonmedical drivers of health (NMDOH) may contribute. Prior research in Mexican American individuals suggested high VI prevalence, but data across more diverse US Hispanic/Latino populations remain limited. Objective: To estimate VI prevalence and assess its associations with CVD risk factors in Hispanic/Latino adults in the US. Design, Setting, and Participants: This cross-sectional study analyzed data from SOL Ojos, an ancillary study of the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Participants were Hispanic/Latino adults aged 40 years or older from community-based cohorts in Chicago, Illinois, and Miami, Florida, who completed HCHS/SOL visit 3 (2020-2024) and were recruited into SOL Ojos from July 1, 2021, to July 1, 2023. Exposures: Individual and cumulative major CVD risk factors: diabetes, hypercholesterolemia, hypertension, obesity, and smoking. Main Outcome and Measures: Age-standardized VI (visual acuity less than or equal to 20/40 in the better-seeing eye), assessed by habitual visual acuity, best-corrected visual acuity, and uncorrected refractive error (correctable to more than 20/40). Odds ratios (ORs) for VI by CVD risk factors were estimated using logistic regression, sequentially adjusting for traditional, biologic, and NMDOH-related confounders. Age-standardized weighted estimates reflected the target population. Results: Among 3288 participants (mean age, 58.7 [95% CI, 57.9-59.5] years; 61.9% [95% CI, 60.2%-63.5%] female), VI prevalence by habitual visual acuity was 7.1% (95% CI, 5.3%-8.8%) in men vs 7.0% (95% CI, 5.2%-8.8%) in women and by best-corrected visual acuity was 1.8% (95% CI, 1.0%-2.6%) in men vs 2.6% (95% CI, 1.6%-3.7%) in women; VI by uncorrected refractive error was 5.2% (95% CI, 3.7%-6.8%) in men vs 4.4% (95% CI, 3.0%-5.8%) in women. VI prevalence varied across Hispanic/Latino backgrounds in men (habitual visual acuity VI range, 4.1% [95% CI, 1.8%-6.4%] to 16.9% [95% CI, 11.6%-22.2%]; uncorrected refractive error range, 2.3% [95% CI, 0.6%-4.0%] to 13.5% [95% CI, 8.1%-18.9%]) and was highest among Mexican men. In fully adjusted models, diabetes was associated with VI assessed by best-corrected visual acuity (OR, 4.65; 95% CI, 2.42-8.91), as were cumulative CVD risk factors vs 1 or none (3 factors: OR, 3.47 [95% CI, 1.45-8.33]; ≥4 factors: OR, 9.80 [95% CI, 4.34-22.13]). ORs were smaller when VI was assessed by habitual visual acuity (eg, diabetes OR, 2.03 [95% CI, 1.37-3.01]). Conclusions and Relevance: In this cross-sectional study of US Hispanic/Latino adults, VI and CVD risk factor prevalence varied by ethnic background, and diabetes and cumulative CVD risk factors were associated with VI. The findings provide updated prevalence estimates and support the need for longitudinal studies of causal relationships between VI and CVD risk factors.
- 1 September 2018
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 193, 184-196
Systemic Disease and Long-term Intraocular Pressure Mean, Peak, and Variability in Nonglaucomatous Eyes
- 1 September 2018
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 193, 184-196
Systemic Disease and Long-term Intraocular Pressure Mean, Peak, and Variability in Nonglaucomatous Eyes
- 1 January 2017
- Published by Elsevier in Ophthalmology Retina
- Vol. 1 (1) , 49-58
Age-Related Macular Degeneration and Mortality in the Age-Related Eye Disease Study (AREDS)
- 1 January 2017
- Published by Elsevier in Ophthalmology Retina
- Vol. 1 (1) , 49-58
Age-Related Macular Degeneration and Mortality in the Age-Related Eye Disease Study (AREDS)
- 2 September 2016
- Published by Springer Nature in Cancer Causes & Control
- Vol. 27 (10) , 1261-1271
The effect of time on racial differences in epithelial ovarian cancer (OVCA) diagnosis stage, overall and by histologic subtypes: a study of the National Cancer Database
Purpose Previous studies assessing racial and ethnic differences in ovarian cancer (OVCA) diagnosis stage fail to present subtype-specific results and provide historic data on cases diagnosed between 10 and 20 years ago. The purpose of this analysis is to assess non-Hispanic Black (NHB) and non-Hispanic White (NHW) differences in late-stage diagnosis including; (1) factors associated with late-stage diagnosis of invasive epithelial OVCA overall and by histologic subtypes, (2) potential changes across time and (3) current patterns of trends in a national cancer registry in the USA and Puerto Rico between 1998 and 2011. Methods NHB and NHW OVCA cases were derived from the National Cancer Database (NCDB). Diagnosis stage was analyzed as a dichotomous and a four level-category variable, respectively; early (stages I and II; localized) versus late (stages III and IV; regional and distant) and stages I, II, III and IV. Diagnosis period was trichotomized (1998–2002, 2003–2007, 2008–2011). Racial differences in stage were tested using Chi-square statistics. Odds ratios (OR) and 95 % confidence intervals (95 % CI) were estimated using multivariable binomial and generalized ordered logistic regressions. Interactions between race and diagnosis period were evaluated. Results Between 1998 and 2011, 11,562 (7.8 %) NHB and 137,106 (92.2 %) NHW were diagnosed with OVCA. In adjusted models, NHB were significantly more likely diagnosed with late-stage OVCA than NHW (ORadj 1.26, 95 % CI 1.19–1.33). Interaction between race and diagnosis period was marginally significant (p value = 0.09), with racial differences in stage decreasing over time (1998–2002: ORadj 1.36, 95 % CI 1.23–1.49; 2003–2007: ORadj 1.27, 95 % CI 1.15–1.39; 2008–2011; ORadj 1.15, 95 % CI 1.05–1.27). NHB were also more likely to be diagnosed with stage 4 high-grade serous (ORadj 1.46, 95 % CI 1.22–1.74), clear cell (ORadj 2.71, 95 % CI 1.94–3.79) and mucinous (ORadj 2.78, 95 % CI 2.24–3.46) carcinomas than NHW. Conclusions Racial differences in late-stage OVCA diagnosis exist; however, these differences are decreasing with time. Within NCDB, NHB are significantly more likely diagnosed with late-stage OVCA and more specifically high-grade serous, clear cell and mucinous carcinomas than NHW.
- 2 September 2016
- Published by Springer Nature in Cancer Causes & Control
- Vol. 27 (10) , 1261-1271
The effect of time on racial differences in epithelial ovarian cancer (OVCA) diagnosis stage, overall and by histologic subtypes: a study of the National Cancer Database
Purpose Previous studies assessing racial and ethnic differences in ovarian cancer (OVCA) diagnosis stage fail to present subtype-specific results and provide historic data on cases diagnosed between 10 and 20 years ago. The purpose of this analysis is to assess non-Hispanic Black (NHB) and non-Hispanic White (NHW) differences in late-stage diagnosis including; (1) factors associated with late-stage diagnosis of invasive epithelial OVCA overall and by histologic subtypes, (2) potential changes across time and (3) current patterns of trends in a national cancer registry in the USA and Puerto Rico between 1998 and 2011. Methods NHB and NHW OVCA cases were derived from the National Cancer Database (NCDB). Diagnosis stage was analyzed as a dichotomous and a four level-category variable, respectively; early (stages I and II; localized) versus late (stages III and IV; regional and distant) and stages I, II, III and IV. Diagnosis period was trichotomized (1998–2002, 2003–2007, 2008–2011). Racial differences in stage were tested using Chi-square statistics. Odds ratios (OR) and 95 % confidence intervals (95 % CI) were estimated using multivariable binomial and generalized ordered logistic regressions. Interactions between race and diagnosis period were evaluated. Results Between 1998 and 2011, 11,562 (7.8 %) NHB and 137,106 (92.2 %) NHW were diagnosed with OVCA. In adjusted models, NHB were significantly more likely diagnosed with late-stage OVCA than NHW (ORadj 1.26, 95 % CI 1.19–1.33). Interaction between race and diagnosis period was marginally significant (p value = 0.09), with racial differences in stage decreasing over time (1998–2002: ORadj 1.36, 95 % CI 1.23–1.49; 2003–2007: ORadj 1.27, 95 % CI 1.15–1.39; 2008–2011; ORadj 1.15, 95 % CI 1.05–1.27). NHB were also more likely to be diagnosed with stage 4 high-grade serous (ORadj 1.46, 95 % CI 1.22–1.74), clear cell (ORadj 2.71, 95 % CI 1.94–3.79) and mucinous (ORadj 2.78, 95 % CI 2.24–3.46) carcinomas than NHW. Conclusions Racial differences in late-stage OVCA diagnosis exist; however, these differences are decreasing with time. Within NCDB, NHB are significantly more likely diagnosed with late-stage OVCA and more specifically high-grade serous, clear cell and mucinous carcinomas than NHW.
- 1 August 2015
- Published by Elsevier in Annals of Epidemiology
- Vol. 25 (8) , 556-563
The influence of neighborhood socioeconomic status and race on survival from ovarian cancer: a population-based analysis of Cook County, Illinois
- 1 August 2015
- Published by Elsevier in Annals of Epidemiology
- Vol. 25 (8) , 556-563
The influence of neighborhood socioeconomic status and race on survival from ovarian cancer: a population-based analysis of Cook County, Illinois
- 1 November 2014
- Published by Elsevier in Gynecologic Oncology
- Vol. 135 (2) , 285-291
The effect of neighborhood-level socioeconomic status on racial differences in ovarian cancer treatment in a population-based analysis in Chicago
- 1 November 2014
- Published by Elsevier in Gynecologic Oncology
- Vol. 135 (2) , 285-291
The effect of neighborhood-level socioeconomic status on racial differences in ovarian cancer treatment in a population-based analysis in Chicago
- 1 January 2010
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 128 (1) , 137-139
Shifting Distribution of Chicago-Area Acanthamoeba Keratitis Cases
Letter from JAMA Ophthalmology — Shifting Distribution of Chicago-Area Acanthamoeba Keratitis Cases
- 1 January 2010
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 128 (1) , 137-139
Shifting Distribution of Chicago-Area Acanthamoeba Keratitis Cases
Letter from JAMA Ophthalmology — Shifting Distribution of Chicago-Area Acanthamoeba Keratitis Cases
- 1 August 2007
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 144 (2) , 169-180.e2
The Association of Contact Lens Solution Use and Acanthamoeba Keratitis
- 1 August 2007
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 144 (2) , 169-180.e2
The Association of Contact Lens Solution Use and Acanthamoeba Keratitis
- 1 August 2006
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 142 (2) , 212-217.e2
Epidemiological Characteristics of a Chicago-area Acanthamoeba Keratitis Outbreak
- 1 August 2006
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 142 (2) , 212-217.e2
Epidemiological Characteristics of a Chicago-area Acanthamoeba Keratitis Outbreak
- 1 December 2005
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 31 (12) , 2287-2292
Contact lens overrefraction variability in corneal power estimation after refractive surgery
To evaluate the accuracy and precision of the contact lens overrefraction (CLO) method in determining corneal refractive power in post-refractive-surgery eyes. Refractive Surgery Service and Contact Lens Service, University of Illinois, Chicago, Illinois, USA. Fourteen eyes of 7 subjects who had a single myopic laser in situ keratomileusis procedure within 12 months with refractive stability were included in this prospective case series. The CLO method was compared with the historical method of predicting the corneal power using 4 different lens fitting strategies and 3 refractive pupil scan sizes (3 mm, 5 mm, and total pupil). Rigid lenses included 3 9.0 mm overall diameter lenses fit flat, steep, and an average of the 2, and a 15.0 mm diameter lens steep fit. Cycloplegic CLO was performed using the autorefractor function of the Nidek OPD-Scan ARK-10000. Results with each strategy were compared with the corneal power estimated with the historical method. The bias (mean of the difference), 95% limits of agreement, and difference versus mean plots for each strategy are presented. In each subject, the CLO-estimated corneal power varied based on lens fit. On average, the bias between CLO and historical methods ranged from -0.38 to +2.42 diopters (D) and was significantly different from 0 in all but 3 strategies. Substantial variability in precision existed between fitting strategies, with the range of the 95% limits of agreement approximating 0.50 D in 2 strategies and 2.59 D in the worst-case scenario. The least precise fitting strategy was use of flat-fitting 9.0 mm diameter lenses. The accuracy and precision of the CLO method of estimating corneal power in post-refractive-surgery eyes was highly variable on the basis of how rigid lense were fit. One of the most commonly used fitting strategies in clinical practice--flat-fitting a 9.0 diameter lens-resulted in the poorest accuracy and precision. Results also suggest use of large-diameter lenses may improve outcomes.
- 1 December 2005
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 31 (12) , 2287-2292
Contact lens overrefraction variability in corneal power estimation after refractive surgery
To evaluate the accuracy and precision of the contact lens overrefraction (CLO) method in determining corneal refractive power in post-refractive-surgery eyes. Refractive Surgery Service and Contact Lens Service, University of Illinois, Chicago, Illinois, USA. Fourteen eyes of 7 subjects who had a single myopic laser in situ keratomileusis procedure within 12 months with refractive stability were included in this prospective case series. The CLO method was compared with the historical method of predicting the corneal power using 4 different lens fitting strategies and 3 refractive pupil scan sizes (3 mm, 5 mm, and total pupil). Rigid lenses included 3 9.0 mm overall diameter lenses fit flat, steep, and an average of the 2, and a 15.0 mm diameter lens steep fit. Cycloplegic CLO was performed using the autorefractor function of the Nidek OPD-Scan ARK-10000. Results with each strategy were compared with the corneal power estimated with the historical method. The bias (mean of the difference), 95% limits of agreement, and difference versus mean plots for each strategy are presented. In each subject, the CLO-estimated corneal power varied based on lens fit. On average, the bias between CLO and historical methods ranged from -0.38 to +2.42 diopters (D) and was significantly different from 0 in all but 3 strategies. Substantial variability in precision existed between fitting strategies, with the range of the 95% limits of agreement approximating 0.50 D in 2 strategies and 2.59 D in the worst-case scenario. The least precise fitting strategy was use of flat-fitting 9.0 mm diameter lenses. The accuracy and precision of the CLO method of estimating corneal power in post-refractive-surgery eyes was highly variable on the basis of how rigid lense were fit. One of the most commonly used fitting strategies in clinical practice--flat-fitting a 9.0 diameter lens-resulted in the poorest accuracy and precision. Results also suggest use of large-diameter lenses may improve outcomes.